The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 15,201–15,300 of 31,469
Dimitroulas, T., Douglas, K., Panoulas, V. F., et al. (2013) · Clinical Rheumatology · doi:10.1007/s10067-013-2283-6 · Cited by 20
Ma, H., Lin, H., Hu, Y., Li, X., He, W., Jin, X., Gao, J., Zhao, N., & Gao, X. (2014) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2014.01.017 · Cited by 20
Soluble CD40 Ligand in Morbidly Obese Patients
Baena‐Fustegueras, J. A., Pardina, E., Balada, E., et al. (2013) · JAMA Surgery · doi:10.1001/jamasurgery.2013.419 · Cited by 20
Lee, Y. S., Kek, B. L. K., Poh, L. K. S., Saw, S., & Loke, K. Y. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318162a0e5 · Cited by 20
Kim, S., Lee, H., Lee, D., Lee, H. S., & Lee, J. (2013) · Metabolism · doi:10.1016/j.metabol.2013.11.015 · Cited by 20
Al‐Daghri, N. M., Al-Attas, O. S., Alokail, M. S., et al. (2009) · PubMed · doi:10.3233/dma-2009-0623 · Cited by 20
Hypothalamo–pituitary–adrenal axis, glucose metabolism and TNF ‐α in narcolepsy
Maurovich‐Horvat, E., Keckeis, M., Lattová, Z., Kemlink, D., Wetter, T., Schuld, A., Šonka, K., & Pollmächer, T. (2014) · Journal of Sleep Research · doi:10.1111/jsr.12138 · Cited by 20
Fernando Carrasco, N., Moreno, M., Verónica Irribarra, P., Rodríguez, L., Martin, M. A., Alarcón, A., Mizón, C., Echenique, C., Saavedra, V., Pizarra, T., et al. (2008) · Revista médica de Chile · doi:10.4067/s0034-98872008000100002 · Cited by 20
Hattersley, J. G., Möhlig, M., Roden, M., Arafat, A. M., von Loeffelholz, C., Nowotny, P., Machann, J., Hierholzer, J., Osterhoff, M. A., Khan, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039029 · Cited by 20
Rhee, E., Hwang, S.-T., Lee, W., Yoon, J.-H., Kim, B. J., Kim, B., Kang, J.-H., Lee, M., Park, J.-R., & Sung, K. (2007) · Endocrine Journal · doi:10.1507/endocrj.k07e-018 · Cited by 20
Impairment of cardiac insulin signaling in fructose-fed ovariectomized female Wistar rats
Žakula, Z., Korićanac, G., Tepavčević, S., Stojiljković, M., Milosavljević, T., & Isenović, E. R. (2010) · European Journal of Nutrition · doi:10.1007/s00394-010-0161-4 · Cited by 20
Serum Fetuin-A levels in women with polycystic ovary syndrome
Gülhan, İ., Bozkaya, G., Öztekin, D. C., Uyar, İ., Kebapçılar, A. G., & Pamuk, B. Ö. (2012) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2494-0 · Cited by 21
Mirza, N. M., Klein, C. J., Palmer, M., McCarter, R., He, J., Ebbeling, C. B., Ludwig, D. S., & Yanovski, J. A. (2011) · International Journal of Pediatric Obesity · doi:10.3109/17477166.2010.544740 · Cited by 20
Kadirvelu, A., Choy, A. M., Mustafa, M. R., & Lang, C. C. (2008) · Cardiovascular Therapeutics · doi:10.1111/j.1755-5922.2008.00064.x · Cited by 20
Incretin secretion and serum DPP-IV activity in Korean patients with type 2 diabetes
Han, S. J., Kim, H. J., Choi, S., KANG, Y. Y., Lee, K. W., & Kim, D. J. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.06.004 · Cited by 20
Yu, F.-J., Huang, M., Chang, W., Chung, H., Wu, C.-Y., Shin, S., & Hsu, C. (2012) · Annals of Nutrition and Metabolism · doi:10.1159/000339265 · Cited by 20
Wong, A. T. Y., Chan, D. C., Ooi, E. M. M., Ng, T. W., Watts, G. F., & Barrett, P. H. R. (2013) · Clinical Science · doi:10.1042/cs20120587 · Cited by 20
Impact of childhood obesity treatment on body composition and metabolic profile
Kalavainen, M., Utriainen, P., Vanninen, E. J., Korppi, M. O., & Nuutinen, O. (2011) · World Journal of Pediatrics · doi:10.1007/s12519-011-0324-2 · Cited by 23
Rubio-Ruiz, M. E., Díaz‐Díaz, E., Cárdenas‐León, M., Argüelles-Medina, R., Sánchez-Canales, P., Larrea-Gallo, F., Soria‐Castro, E., & Guarner‐Lans, V. (2008) · Glycobiology · doi:10.1093/glycob/cwn034 · Cited by 20
Byrkjeland, R., Edvardsen, E., Njerve, I. U., Arnesen, H., Seljeflot, I., & Solheim, S. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-36 · Cited by 24
Abbasi, F., Malhotra, D., Mathur, A., Reaven, G., & Molina, C. (2012) · Diabetes & vascular disease research · doi:10.1177/1479164111433578 · Cited by 24
Li, F., Gao, L., Guan, Q., Hou, X., Wan, Q., Wang, X., & Zhao, J. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0026 · Cited by 20
Prolonged exposure to GH impairs insulin signaling in the heart
Miquet, J. G., Giani, J. F., Martinez, C. S., Muñoz, M. C., González, L., Sotelo, A. I., Boparai, R. K., Masternak, M. M., Bartke, A., Dominici, F. P., et al. (2011) · Journal of Molecular Endocrinology · doi:10.1530/jme-11-0066 · Cited by 20
Utsunomiya, H., Yamamoto, H., Kunita, E., Hidaka, T., & Kihara, Y. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-86 · Cited by 20
Ding, Y., Guo, S., Ma, R., et al. (2015) · Mediators of Inflammation · doi:10.1155/2015/607364 · Cited by 20
Immune Phenotype and Serum Leptin in Children with Obesity-Related Liver Disease
Iorio, R. F., Sepe, A. O., Giannattasio, A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1054 · Cited by 20
Cerebral Blood Flow Links Insulin Resistance and Baroreflex Sensitivity
Ryan, J. P., Sheu, L. K., Verstynen, T., Onyewuenyi, I. C., & Gianaros, P. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083288 · Cited by 23
Minicocci, I., Prisco, C., Montali, A., Costanzo, A. D., Ceci, F., Pigna, G., & Arca, M. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.036 · Cited by 21
Yokoyama, H. (2011) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph8073019 · Cited by 22
Association between Serum 25-Hydroxyvitamin D Level and Insulin Resistance in a Rural Population
Song, B., Kim, H. C., Choi, D. P., et al. (2014) · Yonsei Medical Journal · doi:10.3349/ymj.2014.55.4.1036 · Cited by 20
Choi, E.-S., Rhee, E., Kim, J., Won, J. C., Park, C., Lee, W., Oh, K. W., Park, H., & Kim, S. W. (2008) · Korean Diabetes Journal · doi:10.4093/kdj.2008.32.6.498 · Cited by 20
Smart, M., Dedoussis, G. V., Yiannakouris, N., Grisoni, M.-L., Ken‐Dror, G., Yannakoulia, M., Papoutsakis, C., Louizou, E., Mantzoros, C. S., Melistas, L., et al. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.12.004 · Cited by 20
Balkan, F., Çetin, N., Usluoğulları, C. A., Ünal, O. K., & Usluoğullari, B. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-63 · Cited by 20
Atherogenic indices and prehypertension in obese and non-obese children
Rodríguez‐Morán, M., Guerrero‐Romero, F., Aradillas-García, C., Bermúdez-Peña, C., Simental‐Mendía, L. E., Morales, J. M. V., Rodríguez, M. L. T., & Mendoza, E. D. L. C. (2012) · Diabetes and Vascular Disease Research · doi:10.1177/1479164112440713 · Cited by 20
Collison, K. S., Zaidi, M. Z., Saleh, S. M., et al. (2011) · British Journal Of Nutrition · doi:10.1017/s000711451000588x · Cited by 20
Koiou, E., Τζιόμαλος, Κ., Katsikis, I., Delkos, D., Tsourdi, E. A., & Panidis, D. (2013) · HORMONES · doi:10.14310/horm.2002.1444 · Cited by 20
Ouyang, X., Lou, Q., Gu, L., Ko, G. T. C., Mo, Y., Wu, H., & Bian, R. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0032-5 · Cited by 19
Kew, S., Ye, C., Sermer, M., Connelly, P. W., Hanley, A. J., Zinman, B., & Retnakaran, R. R. (2011) · Diabetes Care · doi:10.2337/dc11-1554 · Cited by 22
Metabolic syndrome and endothelin-1 mediated vasoconstrictor tone in overweight/obese adults
Rocha, N. G., Templeton, D. L., Greiner, J. J., Stauffer, B. L., & DeSouza, C. A. (2014) · Metabolism · doi:10.1016/j.metabol.2014.04.007 · Cited by 20
Li, C., Bai, Y., Hsieh, J., Lee, H., Yang, B., Chen, M., Lin, W.-C., Tsai, C.-F., Tu, P., Wang, S.-J., et al. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.02.003 · Cited by 21
Lavoie, M.-È., RABASA-LHORET, R. P. R., Ziai, S., & Lavoie, J. (2011) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000136 · Cited by 20
Borel, A., Boulet, G., Nazare, J., Smith, J., Alméras, N., Tremblay, A., Bergeron, J., Poirier, P., Carpentier, A. C., & Després, J. (2013) · Diabetes Care · doi:10.2337/dc12-2353 · Cited by 20
Moura, F. A., de Carvalho, L. S. F., Cintra, R. M. R., Martins, N. V. G., Figueiredo, V. N., Silva, J. C. Q. E., Almeida, O. L. R., Coelho, O. R., & Sposito, A. C. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00566.2013 · Cited by 20
Chung, T., Shim, J., & Lee, Y. (2015) · Maturitas · doi:10.1016/j.maturitas.2015.11.011 · Cited by 20
Satirapoj, B., Supasyndh, O., Boonyavarakul, A., et al. (2005) · PubMed · Cited by 20
Leptin-to-adiponectin ratio in obese adolescents with nonalcoholic fatty liver disease
Angın, Y., Arslan, N., & Kuralay, F. (2014) · The Turkish Journal of Pediatrics · doi:10.24953/turkjpediatr.2014.1361 · Cited by 20
Kächele, M., Hennige, A. M., Machann, J., Hieronimus, A., Lamprinou, A., Machicao, F. E., Schick, F., Fritsche, A., Stefan, N., Nürnberg, B., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144494 · Cited by 20
Gutierrez, J. L., Bowden, R. G., & Willoughby, D. S. (2015) · Journal of Dietary Supplements · doi:10.3109/19390211.2015.1110222 · Cited by 20
Huang, D.-W., Chang, W.-C., Wu, J. S., et al. (2016) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b05558 · Cited by 20
Alemzadeh, R., & Kichler, J. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0099 · Cited by 20
Marques, P., Limbert, C., Oliveira, L., Santos, M. I., & Lopes, L. (2017) · International Journal of Adolescent Medicine and Health · doi:10.1515/ijamh-2015-0110 · Cited by 25
Monfort‐Pires, M., & Ferreira, S. R. G. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.02.015 · Cited by 21
Prevalence and possible mechanisms of reactive hypoglycemia in polycystic ovary syndrome
Mumm, H., Altinok, M. L., Henriksen, J. E., Ravn, P., Glintborg, D., & Andersen, M. (2016) · Human Reproduction · doi:10.1093/humrep/dew046 · Cited by 20
Association of serum omentin-1 concentrations with the presence and severity of preeclampsia
Liu, H., Wu, J., Wang, H., Sheng, L., Tang, N., Li, Y., & Hao, T. (2014) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563214541247 · Cited by 19
Regulation of urea synthesis during the acute-phase response in rats
Thomsen, K. L., Jessen, N., Møller, A. B., et al. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00416.2012 · Cited by 20
Markers of insulin resistance in perimenopausal women with endometrial pathology
Kacalska‐Janssen, O., Rajtar-Ciosek, A., Zmaczyński, A., Wyroba, J., Milewicz, T., Krzyczkowska-Sendrakowska, M., & Krzysiek, J. (2013) · Ginekologia Polska · doi:10.17772/gp/1661 · Cited by 20
Hileman, C. O., Carman, T. L., Longenecker, C. T., Labbato, D. E., Storer, N. J., White, C. A., & McComsey, G. A. (2013) · Antiviral Therapy · doi:10.3851/imp2651 · Cited by 20
The influence of type 2 diabetes on serum GH and IGF-I levels in hospitalized Japanese patients
Suda, K., Matsumoto, R., Fukuoka, H., et al. (2016) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2016.03.002 · Cited by 20
Exercise-induced exaggerated blood pressure response in men with the metabolic syndrome
Gaudreault, V., Després, J., Rhéaume, C., et al. (2013) · Blood Pressure Monitoring · doi:10.1097/mbp.0b013e3283646f59 · Cited by 20
Helaly, M. A.-H., Hatata, E.-S. Z., Abuelmagd, M. M., et al. (2013) · Electronic Journal of General Medicine · doi:10.29333/ejgm/82250 · Cited by 20
Svahn, S. L., Väremo, L., Gabrielsson, B. G., Peris, E., Nookaew, I., Grahnemo, L., Sandberg, A., Asterholm, I. W., Jansson, J., Nielsen, J., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155099 · Cited by 20
Masson, W. M., Siniawski, D. A., Lobo, M., et al. (2016) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2016.04.004 · Cited by 20
Brandt, B., Mazaki‐Tovi, S., Hemi, R., et al. (2015) · Journal of Perinatal Medicine · doi:10.1515/jpm-2014-0215 · Cited by 20
Lwow, F., Jędrzejuk, D., Milewicz, A., & Szmigiero, L. (2016) · Experimental Gerontology · doi:10.1016/j.exger.2016.06.007 · Cited by 18
Carraro, J. C. C., Hermsdorff, H. H. M., Mansego, M. L., Zulet, M. Á., Milagro, F. I., Bressan, J., & Martínez, J. A. (2016) · Lifestyle Genomics · doi:10.1159/000448101 · Cited by 21
Ortiz, M. M. L., Garay‐Sevilla, M. E., Tejero, M. E., & Pérez-Luque, E. L. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114516002798 · Cited by 21
QT Interval Shortening After Bariatric Surgery Depends on the Applied Heart Rate Correction Equation
Grasser, E. K., Ernst, B., Thurnheer, M., & Schultes, B. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2393-8 · Cited by 21
Li, J., Wu, N., Dai, W., Jiang, L., Li, Y., Li, S., & Wen, Z. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0458-6 · Cited by 20
Li, J., Lai, H. C., Chen, S., Zhu, H., & Lai, S. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.10.022 · Cited by 19
Kawamoto, R., Ninomiya, D., & Kumagi, T. (2016) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.240.221 · Cited by 21
Elattar, S., Estaphan, S., Mohamed, E., Elzainy, A., & Naguib, M. A. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.11.012 · Cited by 21
Lecube, A., Valladares, S., López‐Cano, C., Gutiérrez-Carrasquilla, L., Ciudin, A., Fort, J. M., Reñé, J. M., Matías‐Guiu, X., de Torres, I. M., Bueno, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166741 · Cited by 20
The influence of GH treatment on glucose homeostasis in girls with Turner Syndrome: a 7 years study
Baronio, F., Mazzanti, L., Girtler, Y., Tamburrino, F., Lupi, F., Longhi, S., Fanolla, A., & Radetti, G. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3179 · Cited by 21
Keller, J., Kahlhöfer, J., Peter, A., & Bosy‐Westphal, A. (2016) · Nutrients · doi:10.3390/nu8120802 · Cited by 21
Hu, W.-Y., Ma, X., Zhou, W., et al. (2017) · Food & Function · doi:10.1039/c6fo01591c · Cited by 20
Effoe, V. S., Wagenknecht, L. E., Echouffo-Tcheugui, J. B., Chen, H., Joseph, J. J., Kalyani, R. R., Bell, R. A., Wu, W.-C. H., Casanova, R., & Bertoni, A. G. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004229 · Cited by 20
The effects of GLP-1 analogues on pre-diabetes of the children
Zhou, Q., Wang, Z.-Y., Zhao, H.-F., & Wang, S. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4129 · Cited by 20
Nutritional status and metabolic profile in neurologically impaired pediatric surgical patients
Pelizzo, G., Calcaterra, V., Carlini, V., Fusillo, M., Manuelli, M. C., Klersy, C., Pasqua, N., Luka, E., Albertini, R., AMICI, M. D., et al. (2017) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2016-0369 · Cited by 20
Bhadoria, A. S., Kedarisetty, C. K., Bihari, C., Kumar, G., Jindal, A., Bhardwaj, A., Shasthry, V., Vyas, T., Benjamin, J., Sharma, S., et al. (2017) · Liver International · doi:10.1111/liv.13396 · Cited by 20
Environmental enteropathy is associated with cardiometabolic risk factors in Peruvian children
Lee, G. O., Olortegui, M. P., Salas, M. S., Yori, P., Trigoso, D. R., Kosek, P., Mispireta, M., Oberhelman, R., Caulfield, L., & Kosek, M. (2017) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174417000071 · Cited by 17
Matikainen, N., Söderlund, S., Björnson, E., Bogl, L. H., Pietiläinen, K. H., Hakkarainen, A., Lundbom, N. M. I., Eliasson, B., Räsänen, S., Rivellese, A. A., et al. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.03.003 · Cited by 22
Muhammad, F. Y., Gezawa, I., Uloko, A. E., Yakasai, A. M., Habib, A. G., & Iliyasu, G. (2017) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.046 · Cited by 20
Healthy eating index and cardiovascular risk factors among Iranian elderly individuals.
Fard, N. R. P., Karimi, M., Saraf‐Bank, S., Baghaei, M. H., Haghighatdoost, F., & Azadbakht, L. (2017) · Europe PMC (PubMed Central) · Cited by 20
Lipoprotein(a)-activated immunity, insulin resistance and new-onset diabetes
Kaya, A., Onat, A., Yüksel, H., Can, G., Yüksel, M., & Ademoğlu, E. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1342508 · Cited by 20
Serum glypican 4 level in obese children and its relation to degree of obesity
Leelalertlauw, C., Korwutthikulrangsri, M., Mahachoklertwattana, P., et al. (2017) · Clinical Endocrinology · doi:10.1111/cen.13435 · Cited by 20
Sun, L., Zhang, X., Wang, T., et al. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4866 · Cited by 20
Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome women
de Medeiros, S. F., Ormond, C. M., de Medeiros, M. A. S., dos Santos, N. V., Banhara, C. R., & Yamamoto, M. M. W. (2017) · Endocrine Connections · doi:10.1530/ec-17-0151 · Cited by 20
Sullivan, S. D., Nash, M. S., Tefara, E., Tinsley, E. A., & Groah, S. L. (2017) · PM&R · doi:10.1016/j.pmrj.2017.08.404 · Cited by 21
Clinical implications of controlled attenuation parameter in a health check‐up cohort
Kwak, M., Chung, G. E., Yang, J. I., Yim, J. Y., Chung, S. J., Jung, S. Y., & Kim, J. S. (2017) · Liver International · doi:10.1111/liv.13558 · Cited by 20
Rehman, S. S. U., Karimi, H., Gillani, S. A., Amjad, I., Ahmad, S., & Yaseen, A. (2017) · Journal of the National Medical Association · doi:10.1016/j.jnma.2017.10.003 · Cited by 20
Bhardwaj, S., Misra, A., Gulati, S., Shajith Anoop, S., Kamal, V. K., & Pandey, R. M. (2017) · Heliyon · doi:10.1016/j.heliyon.2017.e00472 · Cited by 20
Trauma exposure and endothelial function among midlife women
Thurston, R. C., Barinas‐Mitchell, E., von Känel, R., Chang, Y., Koenen, K. C., & Matthews, K. A. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001036 · Cited by 22
da Silva, S. G. L., Terreri, M. T., Abad, T. T. O., Machado, D., Fonseca, F. L. A., Hix, S., Suano-Souza, F. I., Sarni, R. O. S., & Len, C. A. (2018) · Lupus · doi:10.1177/0961203317751851 · Cited by 20
Clustering of Health Behaviors and Cardiorespiratory Fitness Among U.S. Adolescents
Hartz, J., Yingling, L., Ayers, C. R., Adu‐Brimpong, J., Rivers, J. P., Ahuja, C., & Powell‐Wiley, T. M. (2018) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2017.11.298 · Cited by 20
Reddy, M. R. G., Venkata, S., Putcha, U. K., & Jeyakumar, S. M. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2018.01.040 · Cited by 20
Phrommintikul, A., Sa‐nguanmoo, P., Sripetchwandee, J., Vathesatogkit, P., Chattipakorn, N., & Chattipakorn, S. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-23550-9 · Cited by 21
Mburu, J. W., Kingwara, L., Ester, M., & Andrew, N. (2018) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2018.01.002 · Cited by 21
Murao, S., Takata, Y., Yasuda, M., Osawa, H., & Kohi, F. (2018) · American Journal of Hypertension · doi:10.1093/ajh/hpy041 · Cited by 23
Huang, H., Wang, W., Yang, G., Zhang, Y., Li, X., Liu, H., Zhang, L., Zheng, H., & Li, L. (2018) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2018.02.007 · Cited by 20
Dunning, J. R., McVeigh, J. A., Goble, D., & Meiring, R. M. (2018) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000001327 · Cited by 21
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
